Literature DB >> 16354204

Infrared-mediated hyperthermia is effective in the treatment of scleroderma-associated Raynaud's phenomenon.

John Foerster, Susanne Fleischanderl, Stefan Wittstock, Annegret Storch, Hans Meffert, Gabriela Riemekasten, Margitta Worm.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16354204     DOI： 10.1111/j.0022-202X.2005.23938.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  2 in total

1.  Effect of biofeedback and deep oscillation on Raynaud's phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial.

Authors:  Birte Sporbeck; Kirsten Mathiske-Schmidt; Silke Jahr; Dörte Huscher; Mike Becker; Gabriela Riemekasten; Ines Taufmann; Gerd-Rüdiger Burmester; Stephanie Pögel; Anett Reisshauer
Journal:  Rheumatol Int       Date:  2011-04-08       Impact factor: 2.631

2.  Fibromyalgia with severe forms of progression in a multidisciplinary therapy setting with emphasis on hyperthermia therapy--a prospective controlled study.

Authors:  Tobias Romeyke; Hans Christoph Scheuer; Harald Stummer
Journal:  Clin Interv Aging       Date:  2014-12-19       Impact factor: 4.458
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.